DrugDashboards

Betamethasone Dipropionate USP, 0.05%

Betamethasone Dipropionate USP, 0.05% · BETAMETHASONE DIPROPIONATE .5 mg/g · Ointment · Topical · TruPharma LLC

NDC 52817-0824-45 · 1 TUBE in 1 CARTON / 45 g in 1 TUBE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has fallen 30% in a year, to $0.3599 per gram — and generics that get this cheap tend to get abandoned rather than defended. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50Jul 2022Sep 2026$0.3599
51 price points · per GMSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$42.60
Reported to Texas DSHS · 2026 annual filing · TruPharma, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$142,612
3,687 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

38Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30
  • price down 27% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for betamethasone dipropionate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA215186
TE code
AB
Approval date
Feb 18, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Betamethasone Dipropionate USP, 0.05% (Ointment)

LabelerStrengthFirst seenLast seen
TruPharma LLCBETAMETHASONE DIPROPIONATE .5 mg/gJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Betamethasone Dipropionate USP, 0.05% — NDC 52817-0824-45," retrieved September 3, 2026, https://drugdashboards.com/drug/52817082445.

Free to cite with attribution — see how the data is put together.